Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

2.610 +0.090 (+3.57%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,078,973
Open 2.630
Bid (Size) 2.560 (19)
Ask (Size) 2.590 (53)
Prev. Close 2.520
Today's Range 2.370 - 2.680
52wk Range 2.090 - 15.86
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood
Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 
Via Benzinga
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares. 
Via InvestorPlace

Performance

YTD
-69.97%
-69.97%
1 Month
-24.35%
-24.35%
3 Month
-38.15%
-38.15%
6 Month
-80.65%
-80.65%
1 Year
-79.72%
-79.72%

More News

Read More
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
Via InvestorPlace
Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Why Ginkgo Bioworks Stock Is Falling After Hours
Via Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
Via Benzinga
Earnings Scheduled For May 16, 2022
Via Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Via Benzinga
7 Growth Stocks to Buy on the Dip
Via InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
Via InvestorPlace
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
Via InvestorPlace
Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations
Via Benzinga
7 Biggest Loser Stocks That Could Become Surprising Buys
Via InvestorPlace
28 Biggest Movers From Yesterday
Via Benzinga
NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc.
Via SBWire
Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm
Via Benzinga
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
Via InvestorPlace
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
36 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
Here's Why Ginkgo Bioworks Shares Are Rising
Via Benzinga
Is DNA Stock a Buy After Earnings? 3 Analysts Weigh In on Gingko Bioworks.
Via InvestorPlace
8 Materials Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.